This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Matheus Victor: Innovator in Alzheimer's Disease Research
Introduction
Matheus Victor is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of neuroscience, particularly in understanding the role of APOE4 in myelination and its implications for Alzheimer's Disease. His innovative work has the potential to pave the way for new therapeutic strategies.
Latest Patents
Matheus Victor holds a patent titled "APOE4 impairs myelination via altered cholesterol biosynthesis and transport in oligodendroglia." This patent outlines methods for inhibiting amyloid synthesis in subjects using cyclodextrin and its analogs. The research demonstrates that small molecules like cyclodextrin can reverse APOE4-associated cholesterol phenotypes, leading to significantly improved myelination in both human in vitro cultures and APOE4 targeted replacement mice. This work uncovers a pathogenic role of APOE4 in oligodendrocytes and myelination, enabling new therapeutic opportunities for Alzheimer's Disease.
Career Highlights
Matheus Victor is affiliated with the Massachusetts Institute of Technology, where he conducts his research. His work has garnered attention for its innovative approach to addressing the challenges posed by Alzheimer's Disease. With a focus on the biochemical pathways involved in myelination, Victor's research is at the forefront of neuroscience.
Collaborations
Matheus has collaborated with notable colleagues, including Joel Blanchard and Manolis Kellis. These partnerships have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Matheus Victor's contributions to the understanding of APOE4 and its impact on myelination represent a significant advancement in Alzheimer's Disease research. His innovative approaches and collaborative efforts position him as a key figure in the ongoing quest for effective therapies.